ONWARD raises $32m to develop ARC Therapy for spinal cord injury
ONWARD plans to utilise the proceeds to commercialise two technology platforms for programmed stimulation of the spinal cord
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
22 Apr 21
ONWARD plans to utilise the proceeds to commercialise two technology platforms for programmed stimulation of the spinal cord
18 Mar 21
A consortium of institutions led by the University of Leeds is designing and testing the next generation of…
Chondro3 has been recognised by the FDA Breakthrough Devices Program, which aims to improve patient access to new…
12 Feb 21
The FITBONE is a fully implantable system that helps to correct leg length and deformity discrepancies
German speciality chemicals firm Evonik believes its PEEK-based biomaterial has the potential to improve hip dysplasia treatments in…
15 Dec 20
FDA clearance of the Sapphire X system was announced in July of this year as the newest product…
12 Nov 20
This development demonstrates the ongoing commitment and investment that its shareholders, including LBO France, have to this fast-growing…
26 Oct 20
Ceramics have a wide range of uses in medical devices and applications - and these uses are evolving…
06 Oct 20
Duo system demonstrates reduced operative times, shorter hospital stays, and improved clinical outcomes compared to traditional lateral surgery
01 Oct 20
The data-driven design of the CS EDGE helps optimize implant fit while preserving bone